For example, the increased uptake of glutamine alongside glucose has been associated with oral cancers’ resistance to cisplatin, while the production of putrescine via ornithine decarboxylase (ODC) contributes to erlotinib resistance [109,110]. Here, ODC1 is linked to lip and oral cavity carcinoma.